Prior treatments influence immunotherapy response in advanced melanoma
Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade in patients with advanced melanoma depended on whether or not they had ...
Apr 10, 2023
0
5